Ciena reports strong revenue growth, but earnings miss expectations as networking segment leads while routing declines, with management setting a 14% revenue target for fiscal 2025.
Democratic states urge FDA to ease restrictions on safe, effective abortion medication mifepristone
Ciena reports strong revenue growth, but earnings miss expectations as networking segment leads while routing declines, with management setting a 14% revenue target for fiscal 2025.
Democratic states urge FDA to ease restrictions on safe, effective abortion medication mifepristone